UFA
GHDX

US Financial Advisors’s Genomic Health, Inc. GHDX Stock Holding History

US Financial Advisors’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-35
Closed -$1K – 448
2016
Q1 		$1K Hold
35
– – ﹤0.01% 456
2015
Q4 		$1K Hold
35
– – ﹤0.01% 590
2015
Q3 		$1K Hold
35
– – ﹤0.01% 541
2015
Q2 		$1K Buy
+35
New +$987 ﹤0.01% 504

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

US Financial Advisors's GHDX Position: Q2 2016 in Review

US Financial Advisors sold out of Genomic Health, Inc. (GHDX) in Q2 2016, closing a stake of 35 shares — an estimated $1K sold.

US Financial Advisors first reported a position in GHDX in Q2 2015 and held it in 4 quarters. The position peaked at $1K in Q1 2016. 130 funds tracked by Wall St. Rank hold GHDX as of Q2 2016.

  • US Financial Advisors reported no remaining Genomic Health, Inc. position as of Q2 2016 after selling out during the quarter.
  • US Financial Advisors sold 35 Genomic Health, Inc. shares in Q2 2016, an estimated $1K.
  • US Financial Advisors first reported a position in Genomic Health, Inc. in Q2 2015 and held it in 4 quarters.
  • US Financial Advisors's Genomic Health, Inc. position peaked at $1K in Q1 2016.
  • 130 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q2 2016.

Based on US Financial Advisors's 13F filing for Q2 2016, filed 12 Aug 2016.